Ito A, Shintaku I, Satoh M, Ioritani N, Aizawa M, Tochigi T, Kawamura S, Aoki H, Numata I, Takeda A, Namiki S, Namima T, Ikeda Y, Kambe K, Kyan A, Ueno S, Orikasa K, Katoh S, Adachi H, Tokuyama S, Ishidoya S, Yamaguchi T, Arai Y: Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Trial. J Clin Oncol. 31(11):1422-1427(Apr) 2013.
Ito A, Shintaku I, Satoh M, Ioritani N, Tochigi T, Numata I, Namima T, Kambe K, Kyan A, Ueno S, Katoh S, Adachi H, Yamashita S, Yamaguchi T, Arai Y, Tohoku Urological EBMSG: Intravesical seeding of upper urinary tract urothelial carcinoma cells during nephroureterectomy: an exploratory analysis from the THPMG trial. Jpn J Clin Oncol. 43(11):1139-1144(Nov) 2013.
Ishidoya S:Editorial Comment from Dr Ishidoya to Laparoscopic simultaneous bilateral adrenalectomy for testosterone-secreting bilateral adrenal tumors. Int J Urol. 2013 May 2. doi: 10.1111/iju.12190.
Lee SO, Ma Z, Yeh CR, Luo J, Lin TH, Lai KP, Yamashita S, Liang L, Tian J, Li L, Jiang Q, Huang CK, Niu Y, Yeh S, Chang C: New therapy targeting differential androgen receptor signaling in prostate cancer stem/progenitor vs non-stem/progenitor cells. J Mol Cell Biol.5(1):14-26(Feb) 2013.
Lai KP, Huang CK, Chang YJ, Chung CY, Yamashita S, Li L, Lee SO, Yeh S, Chang C: New Therapeutic Approach to Suppress Castration-Resistant Prostate Cancer Using ASC-J9 via Targeting Androgen Receptor in Selective Prostate Cells. Am J Pathol.182(2):460-473(Feb) 2013.
Yamada S, Saito H, Ohara S, Yamashita S, Mitsuzuka K, Namiki S, Miyazato M, Kaiho Y, Ito A, Nakagawa H, Ishidoya S, Arai Y: Salvage Chemotherapy with Docetaxel, Ifosfamide and Nedaplatin (DIN) for Patients with Advanced Germ Cell Tumors: A Preliminary Report. Jpn J Clin Oncol. 43(7):734-9 (Jul) 2013.
Kaiho Y, Yamashita S, Arai Y:Optimization of sexual function outcome following radical prostatectomy using phosphodiesterase type 5 inhibitors. Int J Urol. 20(3):285-9(Mar) 2013.
Mitsuzuka K, Narita S,Koie T,Kaiho Y,Tsuchiya N,Yoneyama T, Kakoi N, Kawamura S, Tochigi T, Habuchi T, Ohyama C, Arai Y: Pathological and biochemical outcomes after radical prostatectomy in men with low-risk prostate cancer meeting the Prostate Cancer International: Active Surveillance criteria. BJU international. 111(6):914-20(May) 2013.
Mitsuzuka K, Koie T, Narita S, Kaiho Y, Yoneyama T, Kawamura S, Tochigi T, Ohyama C, Habuchi T, Arai Y: Is pelvic lymph node dissection required at radical prostatectomy for low-risk prostate cancer?. Int J Urol.20(11):1092-6(Nov) 2013.
Mitsuzuka K, Koie T, Narita S, Kaiho Y, Yoneyama T, Tsuchiya N, et al. Changes in indications and oncological outcomes of radical prostatectomy after 2000--data from 1268 Japanese patients treated with radical prostatectomy between 2000 and 2009. Jpn J Clin Oncol. 43(8):821-6(Aug) 2013.
Mitsuzuka K, Koie T, Narita S, Kaiho Y, Yoneyama T, Tsuchiya N, Kakoi N, Kawamura S, Tochigi T, Ohyama C, Habuchi T, Arai Y: Pathological and oncological outcomes of elderly men with clinically localized prostate cancer. Jpn J Clin Oncol. 43(12):1238-42(Dec) 2013.
Tsuchiya N, Matsui S, Narita S, Kamba T, Mitsuzuka K, Hatakeyama S, Horikawa Y, Inoue T, Saito S, Ohyama C, Arai Y, Ogawa O, Habuchi T: Distinct cancer-specific survival in metastatic prostate cancer patients classified by a panel of single nucleotide polymorphisms of cancer-associated genes. Genes & cancer.4(1-2):54-60(Jan) 2013.
Miyazato M, Kaiho Y, Mitsuzuka K, Yamada S, Namiki S, Saito H, Ito A, Nakagawa H, Ishidoya S, Saito S, Arai Y : Impact of prostate size on urinary quality of life scores after open radical prostatectomy: A single-center experience. Scand J Urol. 48(2):146-52(Apr) 2013.
Yamamuro T, Mitsuzuka K, Sato M, Izumi H, Kawamorita N, Saito H, Kaiho Y, Ito A, Nakagawa H, Arai Y : [A case of papillary renal cell carcinoma mimicking a hemorrhagic renal cyst]. Hinyokika Kiyo. 58(12):679-82(Dec) 2013.
Takahashi S, Hamasuna R, Yasuda M, Ito S, Ito K, Kawai S, Yamaguchi T, Satoh T , Sunaoshi K ,Takeda K, Suzuki N , Maeda S , Nishimura H, Fukuda S, Matsumoto T : Clinical efficacy of sitafloxacin 100 mg twice daily for 7 days for patients with non-gonococcal urethritis. J Infect Chemother.19(5):941-5(Oct) 2013.
Kamiya Y, Shimada Y, Ito S, Kikuchi M, Yasuda M, Kawamura Y,Deguchi T:Analysis of the quinolone-resistance determining region of the gyrA gene and the analogous region of the parC gene in Ureaplasma parvum and Ureaplasma urealyticum detected in first-void urine of men with non-gonococcal urethritis. J Antimicrob Chemother.68(2): 480-482(Feb) 2013.
Shao L, Mori S, Yagishita Y, Okuno T, Hatakeyama Y, Sato T, Kodama T: Lymphatic mapping of mice with systemic lymphoproliferative disorder: Usefulness as an inter-lymph node metastasis model of cancer.J Immunol Methods. 389(1-2):69–78 (Mar) 2013.
Mitsuzuka K, Koie T , Narita S, Kaiho Y, Yoneyama T, Tsuchiya N, Kakoi N, Kawamura S, Tochigi T, Ohyama C, Habuchi T, Yamaguchi T and Arai Y: Changes in indications and oncological outcomes of radical prostatectomy after 2000 – data from 1,268 Japanese patients treated with radical prostatectomy between 2000 and 2009. Jpn J Clin Oncol.43(8):821-6(Aug) 2013.
Narita S, Mitsuzuka K, Yoneyama T, Tsuchiya N, Koie T, Kakoi N, Kawamura S,Kaiho Y, Ohyama C, Tochigi T, Yamaguchi T, Habuchi T, Arai Y: Impact of body mass index on clinicopathological outcome and biochemical recurrence after radical prostatectomy. Prostate Cancer Prostaic Dis.16(3):271-276(Sep) 2013.
Mitsuzuka K, Koie T, Narita S, Kaiho Y, Yoneyama T, Tsuchiya N, Kakoi N, Kawamura S, Tochigi T, Ohyama C, Habuchi T, Arai Y: Pathological and oncological outcomes of elderly men with clinically localized prostate cancer. Jpn J Clin Oncol.43(12):1238-42(Dec) 2013.
Mitsuzuka K, Koie T , Narita S,Kaiho Y, Yoneyama T, Kawamura S, Tochigi T, Ohyama C, Habuchi T, and Arai Y: Is pelvic lymph node dissection required at radical prostatectomy for low-risk prostate cancer ?. Int J Urol.20(11):1092-1096(Nov) 2013.